Cardiometabolic comorbidities in obstructive sleep apnea patients are related to disease severity, nocturnal hypoxemia, and decreased sleep quality

BACKGROUND: Obstructive sleep apnea syndrome (OSA) is currently recognized as an independent risk factor for hypertension, arrhythmia, coronary heart disease, stroke, and metabolic disorders (e.g. diabetes, dyslipidemia). In clinical practice, apnea-hypopnea index (AHI) is the marker used to classif...

Descripción completa

Detalles Bibliográficos
Autores principales: André, Stephanie, Andreozzi, Fabio, Van Overstraeten, Chloé, Ben Youssef, Sidali, Bold, Ionela, Carlier, Sarah, Gruwez, Alexia, Bruyneel, Anne-Violette, Bruyneel, Marie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990595/
https://www.ncbi.nlm.nih.gov/pubmed/31996224
http://dx.doi.org/10.1186/s12931-020-1284-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6990595/
https://www.ncbi.nlm.nih.gov/pubmed/31996224
http://dx.doi.org/10.1186/s12931-020-1284-7

Ejemplares similares